CFX - Colfax to split into two publicly-traded companies

Colfax (CFX) unveils plans to split into two independent companies, a specialty medical technology firm and a fabrication technology firm.Specialty medical technology company will be led by Colfax CEO Matt Trerotola, and the fabrication technology business will be run by Colfax Executive VP Shyam Kambeyanda and retain the ESAB brand name.The medical technology business amassed $309.5M in revenues during Q4, while the fabrication technology arm posted sales of $518.6M.Colfax "has rightfully been awarded a higher multiple, [although] the real heavy lifting still needs to be done," The Value Investor writes in a neutral analysis published on Seeking Alpha.

For further details see:

Colfax to split into two publicly-traded companies